Filing Details
- Accession Number:
- 0001646626-15-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-30 17:22:42
- Reporting Period:
- 2015-09-28
- Filing Date:
- 2015-09-30
- Accepted Time:
- 2015-09-30 17:22:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920465 | La Jolla Pharmaceutical Co | LJPC | Biological Products, (No Disgnostic Substances) (2836) | 330361285 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1646626 | S Lakhmir Chawla | C/O La Jolla Pharmaceutical Company, 10182 Telesis Court, 6Th Floor San Diego CA 92121 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-09-28 | 485 | $27.75 | 485 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
